我们可以预测脏移植功能和移植存活使用低温机器输液参数从循环死亡后的捐赠者吗?
Juliano C M Offerni1,2,3,4,5, Erica Ai Li1, Danny Matti1,3
1Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Transplantation direct
|March 11, 2024
概括
低温机器输液 (HMP) 在高KDPI的捐赠者中改善了移植结果. 特定的HMP流量和阻力参数预测了更好的短期移植功能,有助于在循环死亡后进行捐赠的捐赠者选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植 移植 移植 移植
- 器官的保存 器官的保存
背景情况:
- 低温机器输液 (HMP) 用于减轻循环死亡 (DCD) 捐赠者捐赠后的损伤,特别是那些捐赠者概况指数 (KDPI) 高的捐赠者.
- 了解捐赠者特征, perfusion 参数和移植结果之间的相互作用对于优化 DCD 捐赠者的移植至关重要.
研究的目的:
- 为了研究KDPI,HMP参数 (流量,阻力) 和退出期间的供体生命体征之间的相关性.
- 确定这些因素对短期和长期移植功能和存活的预测价值.
主要方法:
- 使用统计分析,包括ANOVA与Tukey测试,将HMP参数与30天,1年和3年的移植结果 (eGFR,延迟的移植功能) 进行比较.
- 卡普兰-梅尔分析被用来评估移植和接受者的生存率.
主要成果:
- 来自KDPI>50%的捐赠者的脏在移植后30天和1年的EGFR显著改善,当HMP达到平均流量>150mL/min或平均抵抗<0.15mmHg/mL/min时.
- 在Kaplan-Meier分析中,根据KDPI或HMP参数,在3年或5年的移植或接受者存活期中没有观察到显著差异.
结论:
- 在HMP期间的平均阻力和平均流量,当与KDPI一起考虑时,显示出作为短期移植功能的预测因素的潜力.
- 这些HMP参数可能有助于选择DCD供体,并提高移植结果的可预测性.
更多相关视频
07:58Orthotopic Kidney Auto-Transplantation in a Porcine Model Using 24 Hours Organ Preservation And Continuous Telemetry
Published on: August 21, 2020
7.2K
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
726
相关概念视频
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...